SUBSCRIBE
SUBSCRIBE

OctoPlus to Present at London Biotech Investment Forum

April 16, 2007 | 
1 min read
LEIDEN, NETHERLANDS -- (MARKET WIRE) -- April 16, 2007 -- OctoPlus N.V. (Euronext: OCTO), the drug delivery and development company, announces today that its CEO will present at the 3rd Annual London Biotech Investment Forum in London this week.
Events Europe
MORE ON THIS TOPIC
Multiple sclerosis damaged myelin or MS autoimmune disease with healthy nerve with exposed fibre with scarrred cell sheath loss as a 3D illustration.
Multiple sclerosis
Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management
October 6, 2025
 · 
5 min read
 · 
Ben Hargreaves
Victoria Tower Houses of Parliament Westminster Bridge Night Stars London England. Built in the 1800s, House of Commons and House of Lords.
Government
How the UK’s ‘Credibility Challenge’ Hinders Attempts To Reverse Pharma’s Flight
October 1, 2025
 · 
4 min read
 · 
Nick Paul Taylor
Image of padlock on U.S. flag
Job Trends
$100,000 H-1B Fee Leaves Biopharma Grappling With Impact
September 25, 2025
 · 
6 min read
 · 
Angela Gabriel
Illustration of sea storm waves
Layoffs
Layoffs From Just 6 Pharmas Could Wipe Out Over 39,000 Jobs
September 18, 2025
 · 
9 min read
 · 
Angela Gabriel